CC
FSTX

Cannell Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Cannell Capital’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,345
Closed -$46.4K – 95
2022
Q4 		$46.4K Hold
7,345
– – 0.01% 69
2022
Q3 		$38K Buy
7,345
+5,541
+307% +$34.8K 0.01% 80
2022
Q2 		$11K Buy
+1,804
New +$6.08K ﹤0.01% 83

Cannell Capital's FSTX Position: Q1 2023 in Review

Cannell Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 7,345 shares — an estimated $46.4K sold.

Cannell Capital first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $46.4K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Cannell Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cannell Capital sold 7,345 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $46.4K.
  • Cannell Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Cannell Capital's F-star Therapeutics, Inc. Common Stock position peaked at $46.4K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Cannell Capital's 13F filing for Q1 2023, filed 15 May 2023.